GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (FRA:ECQ0) » Definitions » FCF Yield %

Neurizon Therapeutics (FRA:ECQ0) FCF Yield % : -15.74 (As of Mar. 03, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Neurizon Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Neurizon Therapeutics's Trailing 12-Month Free Cash Flow is €-6.39 Mil, and Market Cap is €39.84 Mil. Therefore, Neurizon Therapeutics's FCF Yield % for today is -15.74%.

The historical rank and industry rank for Neurizon Therapeutics's FCF Yield % or its related term are showing as below:

FRA:ECQ0' s FCF Yield % Range Over the Past 10 Years
Min: -48.55   Med: -6.4   Max: -1.31
Current: -15.74


During the past 13 years, the highest FCF Yield % of Neurizon Therapeutics was -1.31%. The lowest was -48.55%. And the median was -6.40%.

FRA:ECQ0's FCF Yield % is ranked worse than
52.53% of 1502 companies
in the Biotechnology industry
Industry Median: -14.15 vs FRA:ECQ0: -15.74

Neurizon Therapeutics's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.


Neurizon Therapeutics FCF Yield % Historical Data

The historical data trend for Neurizon Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics FCF Yield % Chart

Neurizon Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.95 -4.27 -6.79 -7.89 -8.19

Neurizon Therapeutics Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.89 -14.69 -0.25 -16.23 -14.34

Competitive Comparison of Neurizon Therapeutics's FCF Yield %

For the Biotechnology subindustry, Neurizon Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurizon Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurizon Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Neurizon Therapeutics's FCF Yield % falls into.



Neurizon Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Neurizon Therapeutics's FCF Yield % for the fiscal year that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-3.189 / 38.9396
=-8.19%

Neurizon Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.23 * 2 / 45.045999
=-14.34%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurizon Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Neurizon Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurizon Therapeutics Business Description

Traded in Other Exchanges
Address
96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205
Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Neurizon Therapeutics Headlines

No Headlines